Nalbuphine Hydrochloride (McKesson Packaging Services Business Unit of McKesson Corporation)
Welcome to the PulseAid listing for the Nalbuphine Hydrochloride drug offered from McKesson Packaging Services Business Unit of McKesson Corporation. This Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | McKesson Packaging Services Business Unit of McKesson Corporation |
NON-PROPRIETARY NAME: | Nalbuphine Hydrochloride |
SUBSTANCE NAME: | NALBUPHINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA] |
ROUTE: | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2010-05-03 |
END MARKETING DATE: | 0000-00-00 |
Nalbuphine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Nalbuphine Hydrochloride from McKesson Packaging Services Business Unit of McKesson Corporation |
LABELER NAME: | McKesson Packaging Services Business Unit of McKesson Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/mL) |
START MARKETING DATE: | 2010-05-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63739-466_ee8fe2ea-a6c7-485e-bea9-1b94ff66b05c |
PRODUCT NDC: | 63739-466 |
APPLICATION NUMBER: | ANDA070916 |
Other NALBUPHINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: